Your Experience Can Help Others.
Pausabilities offers you the chance to tell other wommen how hormone therapy has made a difference in your life. WYTHES WOMEN'S MENOPAUSE NETWORK
Have you been bothered by menopausal symptoms—the hot flashes and night sweats that may have disrupted your life or the vaginal dryness that may have caused sexual discomfort? Have you found relief with PREMARIN?
If you have, here's a unique opportunity to share information with women who are experiencing menopausal symptoms and may be considering PREMARIN.
By becoming a member of the Pausabilities Network, you could:
- Reach out to women who may benefit from your experience
- Talk about your own menopausal symptoms and hormone therapy
- Share how your treatment may have made a difference
- Speak to health care professionals to share your experiences with menopause and the effect of your treatment
- Be interviewed by members of the media
- Be eligible to participate in marketing and menopausal health programs
If you would like to learn more about the program or would like the opportunity to join, click here to have a brochure sent to you. Or, for more information, please call 1-800-951-4948 or send an e-mail to info@pausabilities.com.
Click here for further information
Important Safety Information
What is the most important information you should know about PREMARIN (estrogens), PREMPRO (a combination of estrogens and a progestin), or PREMARIN Vaginal Cream (a cream of estrogens)?
Estrogens increase the chance of getting cancer of the uterus.
Report any unusual vaginal bleeding right away while you are using these products. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your health care provider should check any unusual vaginal bleeding to find out the cause.
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes, or dementia.
Using estrogens, with or without progestins, may increase your chance of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens, with or without progestins, may increase your chance of getting dementia, based on a study of women age 65 years or older. You and your health care provider should talk regularly about whether you still need treatment with estrogens.
PREMARIN® (conjugated estrogens tablets, USP) is used after menopause to reduce moderate to severe hot flashes; to treat moderate to severe dryness, itching, and burning, in and around the vagina; and to help reduce your chances of getting osteoporosis (thin weak bones).
PREMPRO® (conjugated estrogens/medroxyprogesterone acetate tablets) is used after menopause in women who have a uterus to reduce moderate to severe hot flashes; to treat moderate to severe dryness, itching, and burning, in and around the vagina; and to help reduce your chances of getting osteoporosis (thin weak bones).
PREMARIN® (conjugated estrogens) Vaginal Cream is used after menopause to treat moderate to severe dryness, itching, and burning, in and around the vagina.
PREMARIN and PREMPRO should be used at the lowest effective dose and for the shortest duration consistent with your treatment goals and risks. If you are using or are considering using PREMARIN or PREMPRO only to treat your symptoms of vaginal dryness, consider topical therapies first. If you are using or are considering using PREMARIN and PREMPRO only to prevent osteoporosis due to menopause, talk with your health care professional about whether a different treatment or medicine without estrogens might be better for you.
PREMARIN, PREMPRO, and PREMARIN Vaginal Cream should not be used if you have unusual vaginal bleeding, have or had cancer of the breast or uterus, had a stroke or heart attack in the past year, have or had blood clots, have or had liver problems, are allergic to any of the ingredients in PREMARIN, PREMPRO, or PREMARIN Vaginal Cream, or think you may be pregnant. In general, the addition of a progestin is recommended for women with a uterus to reduce the chance of getting cancer of the uterus.
In a clinical trial, the most commonly reported (≥5%) side effects that occurred more frequently with PREMARIN than with placebo were vaginitis due to yeast or other causes, vaginal bleeding, painful menstruation, and leg cramps.
In a clinical trial, the most commonly reported (≥5%) side effects that occurred more frequently with PREMPRO 0.45 mg/1.5 mg and PREMPRO 0.625 mg/2.5 mg than with placebo were breast pain/enlargement, vaginitis due to yeast or other causes, leg cramps, vaginal spotting/bleeding, and painful menstruation. In a clinical trial, there was no difference in the commonly reported (≥5%) side effects for women taking PREMPRO 0.3 mg/1.5 mg compared to those taking placebo.
The most commonly reported side effects of PREMARIN Vaginal Cream include vaginal discomfort or pain, breast pain, vaginitis, and itching.
